Antibiotics: Technologies and Global Markets

Abstract
Report Scope:

This report is focused on newer drugs and innovations in chemical compounds, recently launched or in development. Specifically excluded from the scope of research are vector or mosquito control, drugs used for symptomatic treatment and not for the elimination of the virus from the host and details on manufacturers and suppliers of non-branded generics. This report will also highlight the current and future market potential of antibiotics with detailed analysis of the competitive environment. Drivers, restraints, opportunities, pricing analysis, impact of COVID-19, other infectious diseases and a regulatory scenario assessment are covered, along with a market projection for 2027 and market share assessment for key players.

The report segments the market for antibiotics based on product type, route of administration, application and geographical region. Based on product type, the market is segmented into cell wall inhibitors, protein inhibitors, DNA and other inhibitors (RNA, mycolic acid, folic acid). Based on route of administration, the market is segmented into oral and topical.

By geographical region, the market has been segmented into North America, Europe, Asia-Pacific, South America and the Middle East and Africa. Detailed analysis of major countries (U.S., Germany, UK, Italy, France, Spain, Japan, China, India, Brazil, Mexico, GCC countries and South Africa) will be covered in the regional segment. For market estimates, data will be provided for 2021 as the base year, with estimates for 2022 and forecast value for 2027.

Report Includes:

- 22 data tables and 16 additional tables
- An overview of the global market for antibiotics within the pharmaceutical industry
- Analyses of the global market trends, with data corresponding to market size for 2019-2022, estimates for 2023, and projections of compound annual growth rates (CAGRs) through 2027
- Information on market growth drivers and opportunities, industry supply chain structure, regulatory developments, technological advancements, and demographic shifts shaping the overall antibiotics marketplace
- Evaluation of market growth during the forecast period, and deep dive of market share analysis data basis of product type, product, route of administration, end-user, and geographical region
- Country specific data and analysis for the U.S., Germany, the U.K., Italy, France, Spain, Japan, China, India, Brazil, Mexico, GCC countries and South Africa
- Identification of the companies best positioned to meet the global market demand for antibiotic drugs on the basis of their proprietary technologies, M&A deals, collaborations, JVs and other strategic alliances
- Company profiles of major players within the industry, including Abbott, F. Hoffmann-La Roche AG, Merck & Co. Inc., Pfizer Inc. and Sanofi

Content
Table of Contents

Chapter 1 Introduction
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
What's New in This Update?
Information Sources
Methodology
Geographic Breakdown
Analyst's Credentials
BCC Custom Research
Related BCC Research Reports
Chapter 2 Summary and Highlights
Chapter 3 Market and Technology Background
Overview of Antibiotics
Common Side Effects of Antibiotics
Classification of Antibiotics
Cell Wall Inhibitors
Protein Inhibitors
DNA Inhibitors
Other Antibiotic Classes
Antibiotic Classification, by Source
Overview of Gram-Negative and Gram-Positive Bacteria
Route of Administration
Trends in the Market for Antibiotics
New Antibiotic Development
Antibiotic Drug Development, Smaller Pharmaceutical Firms
Growing Public/Private Partnerships
Chapter 4 Market Dynamics
Market Drivers
Growth Driven by Antibiotics
Rising Elder Population and Infection Rate
Increasing Hospital-acquired Infections
Improved Awareness
Market Restraints
Antibiotic-resistant Infections
Generics
Declining R&D Investment
Side Effects of Antibiotics
Market Opportunities
Market Expansion
Novel Antibacterial Agents
Chapter 5 Market Breakdown, by Product
Global Market for Antibiotics by Product
Cell Wall Inhibitors
Protein Inhibitors
DNA Inhibitors
Other Types of Inhibitors
Chapter 6 Market Breakdown, by Route of Administration
Global Market for Antibiotics by Route of Administration
Oral Antibiotics
Topical Antibiotics
Other Routes of Administration
Chapter 7 Market Breakdown, by Region
Global Market for Antibiotics by Region
North America
Europe
Asia-Pacific
Latin America
Middle East and Africa
Chapter 8 Impact of COVID-19 on the Pharmaceutical Industry
Short-term Impact
Change in Demand
Shift of Communication and Promotions to Remote Interactions
R&D Changes
Long-term Impact
Delayed Approvals for Non-COVID-related Pharmaceutical Products
Self-sufficiency in Pharma
Pharmaceutical Industry Growth Slowdown
Changes in Consumption Trends in Health-related Products
Chapter 9 Clinical Developments and Pipeline Products
Respiratory Tract Infections
Chapter 10 Value Chain Analysis
Introduction
China: Center of Microbial Threat
Chapter 11 Regulatory Scenario
FDA and International Regulation
Recent Regulatory Reforms
Ketek Case Study
Chapter 12 Competitive Landscape
Global Company Market Share Analysis
Mergers, Collaborations, Partnerships and Acquisitions
Chapter 13 Company Profiles
ABBOTT
F. HOFFMANN-LA ROCHE AG
GLAXOSMITHKLINE PLC
JOHNSON & JOHNSON
MERCK & CO. INC.
PFIZER INC.
SANOFI
VIATRIS INC.
Chapter 14 Appendix: Acronyms

List of Tables
Summary Table A : Global Market for Antibiotics, by Product, Through 2027
Summary Table B : Global Market for Antibiotics, by Route of Administration, Through 2027
Table 1 : Major Differences, Gram-Positive and Gram-Negative Organisms
Table 2 : Proportion of Resistant Strains, by WHO Region
Table 3 : Global Market for Antibiotics, by Product, Through 2027
Table 4 : Global Market for Cell Wall Inhibitor, by Product, Through 2027
Table 5 : Global Market for Cell Wall Inhibitors, by Region, Through 2027
Table 6 : Global Market for Protein Inhibitors, by Product, Through 2027
Table 7 : Global Market for Protein Inhibitors, by Region, Through 2025
Table 8 : Global Market for DNA Inhibitors, by Product, Through 2027
Table 9 : Global Market for DNA Inhibitors, by Region, Through 2027
Table 10 : Global Market for Other Types of Inhibitors, by Region, Through 2027
Table 11 : Global Market for Antibiotics, by Route of Administration, Through 2027
Table 12 : Global Market for Antibiotics, by Region, Through 2027
Table 13 : North American Market for Antibiotics, by Product, Through 2027
Table 14 : North American Market for Antibiotics, by Country, Through 2027
Table 15 : European Market for Antibiotics, by Product, Through 2025
Table 16 : European Market for Antibiotics, by Country, Through 2025
Table 17 : Asia-Pacific Market for Antibiotics, by Product, Through 2027
Table 18 : Asia-Pacific Market for Antibiotics, by Country, Through 2027
Table 19 : Latin American Market for Antibiotics, by Product, Through 2027
Table 20 : Latin American Market for Antibiotics, by Country, Through 2025
Table 21 : Middle Eastern and African Market for Antibiotics, by Product, Through 2027
Table 22 : Middle Eastern and African Market for Antibiotics, by Country, Through 2027
Table 23 : Antibiotics and Combinations in Global Clinical Development, Recent Approvals,2023
Table 24 : FDA-approved Antibacterial Drugs, 2018
Table 25 : FDA-Approved Antibacterial Drugs, 2019
Table 26 : Abbott: Antibiotics Product Portfolio
Table 27 : F. Hoffmann-La Roche AG: Antibiotics Product Portfolio
Table 28 : GlaxoSmithKline Plc: Antibiotics Product Portfolio
Table 29 : Johnson & Johnson: Antibiotics Product Portfolio
Table 30 : Merck & Co. Inc.: Antibiotics Product Portfolio
Table 31 : Merck & Co. Inc.: Antibiotic Drug Overview
Table 32 : Pfizer Inc.: Antibiotics Product Portfolio
Table 33 : Sanofi: Antibiotics Product Portfolio
Table 34 : Sanofi S.A.: Antibiotic Drugs Overview
Table 35 : Vitaris Inc.: Antibiotics Product Portfolio
Table 36 : Acronyms Used in this Report